Identity |
Alias_names | USP3L |
ubiquitin specific protease 22 | |
ubiquitin specific peptidase 3-like | |
Alias_symbol (synonym) | KIAA1063 |
Other alias | |
HGNC (Hugo) | USP22 |
LocusID (NCBI) | 23326 |
Atlas_Id | 43796 |
Location | 17p11.2 [Link to chromosome band 17p11] |
Location_base_pair | Starts at 20999593 and ends at 21043039 bp from pter ( according to hg38-Dec_2013) |
Fusion genes (updated 2017) | Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands) |
BOLA3 (2p13.1) / USP22 (17p11.2) | EXOC7 (17q25.1) / USP22 (17p11.2) | IFNAR1 (21q22.11) / USP22 (17p11.2) | |
LIMA1 (12q13.12) / USP22 (17p11.2) | MRPL52 (14q11.2) / USP22 (17p11.2) | NOL7 (6p23) / USP22 (17p11.2) | |
RMI2 (16p13.13) / USP22 (17p11.2) | TMEM232 (5q22.1) / USP22 (17p11.2) | UCHL1 (4p13) / USP22 (17p11.2) | |
USP22 (17p11.2) / ATP2A3 (17p13.2) | USP22 (17p11.2) / CA7 (16q22.1) | USP22 (17p11.2) / DHCR24 (1p32.3) | |
USP22 (17p11.2) / MYH10 (17p13.1) | USP22 (17p11.2) / MYO19 (17q12) | USP22 (17p11.2) / ORC6 (16q11.2) | |
USP22 (17p11.2) / PRIM1 (12q13.3) | USP22 (17p11.2) / RUSC2 (9p13.3) | USP22 (17p11.2) / SLC39A11 (17q24.3) | |
USP22 (17p11.2) / SPACA3 (17q11.2) | USP22 (17p11.2) / USP22 (17p11.2) | EXOC7 17q25.1 / USP22 17p11.2 | |
USP22 17p11.2 / ATP2A3 17p13.2 | USP22 17p11.2 / MYH10 17p13.1 | USP22 17p11.2 / MYO19 17q12 | |
USP22 17p11.2 / SLC39A11 17q24.3 | USP22 17p11.2 / SPACA3 17q11.2 |
Note | Non-annotated gene. Preliminary data : if you are an author |
DNA/RNA |
Other Leukemias implicated (Data extracted from papers in the Atlas) [ 2 ] |
t(16;17)(q22;p11) CA7/USP22
t(16;17)(q22;p11) USP22/CA7 |
Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 8 ] |
External links |
Genes in title | automatic search in PubMed |
REVIEW articles | automatic search in PubMed |
Last year publications | automatic search in PubMed |
© Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Wed Nov 13 18:14:35 CET 2019 |
For comments and suggestions or contributions, please contact us